Photo Gallery

Login

Search

News & Updation

  • Updated Version
  • WJPPS introducing updated version of OSTS (online submission and tracking system), which have dedicated control panel for both author and reviewer. Using this control panel author can submit manuscript
  • Call for Paper
    • WJPPS  Invited to submit your valuable manuscripts for Coming Issue.
  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.
  •  
  • WJPPS Impact Factor
  • Its our Pleasure to Inform you that WJPPS Impact Factor has been increased from  7.454 to 7.632  due to high quality Publication at International Level

  • ICV
  • WJPPS Rank with Index Copernicus Value 84.65 due to high reputation at International Level

  • WJPPS AUGUST ISSUE PUBLISHED
  • AUGUST 2020 Issue has been successfully launched on 1 August 2020.

Abstract

PRECLINICAL PHARMACOKINETIC EVALUATION OF RITONAVIR TABLETS FORMULATED EMPLOYING ? CD AND SOLUPLUS

K. Ravi Shankar, Dr. KPR Chowdary* and A. Sambasiva Rao

ABSTRACT

Ritonavir, a widely prescribed BCS class II antiretroviral drug exhibit low and variable oral bioavailability due to its poor aqueous solubility and needs enhancement in the dissolution rate in its formulation development. We have earlier reported optimization of ritonavir tablet formulation employing β CD and Soluplus to achieve NLT 85 percent dissolution in 15 min by 22 factorial design. The optimized ritonavir (50 mg) tablet formulation prepared employing βCD (137.5 mg /tablet) and Soluplus (0.75 mg/ tablet) gave 86.25 % dissolution in 15 min fulfilling the target dissolution set. The objective of the present study is pharmacokinetic evaluation of optimized ritonavir tablets formulated employing βCD and Soluplus for their in vivo performance in comparison to plain tablets in healthy rabbits. The study was carried out as per a cross over design. The elimination characteristics of ritonavir have not changed when it was formulated as optimised tablets with βCD and Soluplus. Optimised ritonavir tablets gave rapid and higher absorption and bioavailability of ritonavir when compared to plain tablets. A 5.52 fold and 1.67 fold increase in absorption rate ( Ka) and (AUC) âˆÅ¾0 was observed with optimised ritonavir tablets formulated with βCD and Soluplus when compared to plain tablets.

Keywords: Ritonavir, Pharmacokinetics, Optimization, Pre-clinical Evaluation, ? Cyclodextrin.


[Full Text Article]

Call for Paper

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Online Submission

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Email & SMS Alert

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More